Barclays raised the firm’s price target on Ceva (CEVA) to $40 from $34 and keeps an Overweight rating on the shares. The company reported 21% year-over-year revenue growth in Q4, higher than the top end of company guidance, the analyst tells investors in a research note. The firm thinks Ceva’s 2025 “looks de-risked” given revenue guidance of 9% at the midpoint.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CEVA:
